Clinical Trials Sponsored by Mercy Foundation

Total 20601 results

Mercy Medical Center
First Candle Foundation

Completed

Promoting Fetal Movement Monitoring: Improving Birth Outcomes

Fetal Kick Counting

United States
PETHEMA Foundation
Merck Sharp & Dohme LLC

Completed

AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors (AMENO-2)

Lymphoma | Leukemia

Spain
Children's Mercy Hospital Kansas City
The Gerber Foundation

Enrolling by invitation

CHAMP For the Feeder: Tube Feeding Study

Feeding Disorders

United States
Children's Mercy Hospital Kansas City
The Gerber Foundation

Enrolling by invitation

CHAMP App Feeding Difficulties Repository

Feeding and Eating Disorders of Childhood | Gastrostomy | Feeding Disorder of Infancy and Childhood

United States
Mercy Health System
Rockford Memorial Hospital Development Foundation

Terminated

The Effects of Probiotic Supplementation on Extremely Low Birthweight Infants

Feeding Tolerance

United States
Mercy Research
ImpediMed Limited; Mercy Foundation; St. Louis Men's Group Against Cancer; Juzo...

Active, not recruiting

Subclinical Lymphedema Treatment Study (SLT)

Breast Cancer-related Subclinical Lymphedema

United States
Children's Mercy Hospital Kansas City
Merck Sharp & Dohme LLC

Completed

Montelukast in the Treatment of Duodenal Eosinophilia

Dyspepsia | Eosinophilic Gastroenteritis

United States
Children's Mercy Hospital Kansas City
Robert Wood Johnson Foundation

Completed

Outcomes From an Asthma Disease Management Program

Asthma

United States
Children's Mercy Hospital Kansas City
Katherine Berry Richardson Foundation

Completed

Vancomycin Associated Red Man Syndrome (RMS)

Red Man Syndrome

United States
Mercy Medical Center
Susan G. Komen Breast Cancer Foundation

Completed

An Intervention to Decrease Fatigue Among Breast Cancer Survivors

Fatigue After Adjuvant Breast Cancer Treatment

United States
RTOG Foundation, Inc.
Merck Sharp & Dohme LLC

Recruiting

SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma (KEYSTROKE)

Head and Neck Squamous Cell Carcinoma (HNSCC)

Canada, United States
Merck Sharp & Dohme LLC
Cystic Fibrosis Foundation

Completed

Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease

Cystic Fibrosis
NEAT ID Foundation
Merck Sharp & Dohme LLC

Completed

A Cohort Study of Use of Doravirine (DOR) Based Regimens in Clinical Practice in Europe DoRavirine Europe Real World/ (DrEW)

HIV I Infection

France, United Kingdom
ETOP IBCSG Partners Foundation
Merck Sharp & Dohme LLC; Frontier Science Foundation, Hellas

Completed

PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma (PROMISE-meso)

Pleural Mesothelioma Malignant Advanced

United Kingdom, Switzerland, Spain
Fundacion GESICA
Merck Sharp & Dohme LLC

Recruiting

A Dengue Sero-prevalence Study in the Metropolitan Area of Buenos Aires

Flavivirus Infections | Dengue

Argentina
Alliance Foundation Trials, LLC.
Merck Sharp & Dohme LLC

Terminated

Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer

Small Cell Lung Cancer

United States
Alliance Foundation Trials, LLC.
Merck Sharp & Dohme LLC

Completed

Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC

Non-Small Cell Lung Cancer

United States
OncoC4, Inc.
Merck Sharp & Dohme LLC; GOG Foundation

Recruiting

ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer (PRESERVE-004)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | High Grade Serous Adenocarcinoma of Ovary

United States
Mercy Research

Completed

Stereotactic Body Radiotherapy for Head and Neck Tumors

Nasopharyngeal Carcinoma | Squamous Cell Carcinoma of the Head and Neck | Salivary Gland Cancer | Paraganglioma of Head and Neck | Head and Neck Sarcoma | Chordoma of Head and Neck | Chondrosarcoma of Head and Neck | Angiofibroma of Head and Neck

United States
Mercy Research

Completed

Ultravision Visual Clearing System in Laparoscopic Hysterectomy and Myomectomy

Pain | Hysterectomy | Myomectomy

United States
Mercy Research

Completed

Stereotactic Body Radiotherapy for Unresectable Pancreatic Cancer

Pancreatic Cancer

United States
Mercy Research

Withdrawn

Comparison of Decolonization of Methicillin-resistant Staphylococcus Aureus (MRSA) Using Theraworx (SJMRSA)

Methicillin-Resistant Staphylococcus Aureus
Mercy Research

Terminated

Application of the ICE-T Postoperative Multimodal Pain Regimen to Laparoscopic Hysterectomy

Pain, Postoperative

United States
Mercy Research

Completed

Patient Anxiety Associated With Lymphedema Surveillance Method

Anxiety

United States
Mercy Research

Completed

Stereotactic Body Radiotherapy for Spine Tumors

Arteriovenous Malformations | Neurofibroma | Chordoma | Meningioma | Schwannoma | Spinal Metastases | Paragangliomas | Vertebral Metastases | Benign Spinal Tumors

United States
Mercy Research

Completed

Stereotactic Body Radiotherapy for Liver Tumors

Hepatocellular Carcinoma | Intrahepatic Cholangiocarcinoma | Liver Metastases

United States
Mercy Research

Withdrawn

Surgical Treatment Comparison for Recurrent Lumbar Disc Herniation

Low Back Pain | Recurrent Lumbar Disc Herniation
Mercy Research

Completed

Ultravision™ System to Facilitate Low Impact Laparoscopic Surgery for Endometriosis

Endometriosis

United States
Mercy Research

Completed

Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml® (Mammosite ML)

Breast Cancer | Ductal Carcinoma in Situ

United States
Mercy Research

Completed

Stereotactic Body Radiotherapy for Prostate Cancer

Prostate Cancer

United States
Mercy Research

Withdrawn

VitalConnect VitalPatch ECG Interpretation/Arrhythmia Detection

Arrythmia, Cardiac

United States
Mercy Research

Completed

A Comparison of Meperidine for Post-Cesarean Analgesia: Bolus Versus Infusion and Bolus

Cesarean Section

United States
Mercy Research

Completed

The Effect of Three Different Fluids(Albumin 5%, Normal Saline, Hydroxyethyl Starch 130 kD) on Microcirculation in Severe Sepsis/Septic Shock Patients

Septic Shock | Severe Sepsis | Microcirculation

United States
Indiana University
Merck Sharp & Dohme LLC; National Kidney Foundation

Completed

The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients

Chronic Kidney Disease | Dialysis

United States
Royal Marsden NHS Foundation Trust
Merck KGaA, Darmstadt, Germany

Active, not recruiting

Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma

Soft-tissue Sarcoma

United Kingdom
Royal Marsden NHS Foundation Trust
Merck Sharp & Dohme LLC

Active, not recruiting

Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma (GEMMK)

Sarcoma

United Kingdom
The Christie NHS Foundation Trust
Merck Sharp & Dohme LLC

Completed

Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy (eSCOUT)

Metastatic Colorectal Cancer

United Kingdom
Fundacion SEIMC-GESIDA
Merck Sharp & Dohme LLC

Completed

A Clinical Trial to Evaluate the Immunogenicity of the Nonavalent Vaccine Against Human Papillomavirus in Men Infected by HIV Who Have Sex With Men. GESIDA 10017 (GESIDA10017)

HIV Infections

Spain
Royal Marsden NHS Foundation Trust
Merck Sharp & Dohme LLC

Terminated

Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma (MESO-PRIME)

Advanced Malignant Pleural Mesothelioma

United Kingdom
Royal Marsden NHS Foundation Trust
Merck KGaA, Darmstadt, Germany

Active, not recruiting

Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric Cancer (ICONIC)

Gastric Adenocarcinoma | Oesophageal Adenocarcinoma

United Kingdom
Jhpiego
Bill and Melinda Gates Foundation; Merck for Mothers

Completed

Postpregnancy Family Planning Choices in Public and Private Sectors in Kenya and Indonesia (PPFP Choices)

Post-pregnancy Family Planning | Capacity Building of Healthcare Providers

Indonesia
Fundacion SEIMC-GESIDA
Merck Sharp & Dohme LLC

Completed

Bezlotoxumab - in "Real Life" - During the First Episode of Clostridium Difficile Infection in Patients With High Risk of Recurrence. (BEFORE)

Clostridium Difficile Infection

Spain
Fundacion SEIMC-GESIDA
Merck Sharp & Dohme LLC

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide as a First-line Treatment in Naïve Patients With HIV-1 Infection With Severe Immunosuppression (GENIS)

HIV Infections | Severe Immunosuppression

Spain
Royal Marsden NHS Foundation Trust
Merck Sharp & Dohme LLC

Terminated

PembRolIzuMab and Stereotactic Body Radiotherapy In Metastatic Non-small-cell lunG Cancer Patients (PRIMING)

Metastatic Non-small-cell lunG Cancer

United Kingdom
Papworth Hospital NHS Foundation Trust
Merck Sharp & Dohme LLC

Completed

Serum Bio-markers in Pulmonary Hypertension

Pulmonary Hypertension, Primary, 4

United Kingdom
PETHEMA Foundation
Merck Sharp & Dohme LLC; Adknoma Health Research

Completed

Pembrolizumab (MK-3475) in MM Patients With Residual Disease

Multiple Myeloma

Spain
Royal Marsden NHS Foundation Trust
Merck Sharp & Dohme LLC

Withdrawn

A Study of Anti-PD-1 (Pembrolizumab) Therapy in Metastatic Melanoma (ADAPTeM) (ADAPTeM)

Advanced Melanoma
Royal Marsden NHS Foundation Trust
Merck Serono International SA

Terminated

A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU) (PERU)

Pancreatic Cancer

United Kingdom
University Hospital, Bordeaux
Merck Serono International SA; ARSEP foundation

Completed

Randomised Controlled Clinical Trial of Cognitive Rehabilitation in Multiple Sclerosis (REACTIV)

Multiple Sclerosis | Cognitive Rehabilitation

France
Regenstrief Institute, Inc.
Merck Sharp & Dohme LLC; National Sleep Foundation

Unknown

Testing Utility of Commercially Available Sleep Trackers for Physician-Patient Communication

Insomnia

United States

Clinical Trials Sponsored by Mercy Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations